PYC Therapeutics Limited carries a market capitalization of 906.64M, placing it among publicly traded companies globally.
| Market Cap | 906.64M |
| Enterprise Value | N/A |
PYC Therapeutics Limited's stock has gained approximately 7.24138% over the past 52 weeks. The 50-day moving average sits at 1.36, while the 200-day moving average is 1.38.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.24138% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 1.38 |
| Average Volume (20 Days) | N/A |
PYC Therapeutics Limited's most recent stock split took place on November 15, 2024 with a 10:1 split ratio.
| Last Split Date | 11/15/2024 |
| Split Ratio | 10:1 |